DISEASE INDICATIONS: Progressive Familial Intrahepatic Cholestasis
MANUFACTURER: Albireo Pharma
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Bylvay, known by its generic name Odevixibat, is a pharmaceutical medication used to treat a rare genetic disorder known as progressive familial intrahepatic cholestasis (PFIC).
DISEASE INDICATIONS: Atopic Dermatitis
MANUFACTURER: Pfizer Limited
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Pharmaceuticals and Medical Devices Agency (PMDA)
Medicines & Healthcare products Regulatory Agency (MHRA)
Cibinqo (abrocitinib) is a prescription medicine used to treat adults and children 12 years of age and older with moderate-to-severe atopic dermatitis (eczema) that did not respond to other treatment and is not well controlled with prescription medicines, including biologics, or when they cannot be tolerated.
Crysvita (burosumab) is a human monoclonal antibody medication used to treat X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia (TIO) in adults and children 6 months of age and older. It is the first and only FDA-approved treatment for XLH.
CHARACTERISTICS
ACTIVE HALF-LIFE 2-3 DAYS
CLASSIFICATION ANABOLIC STEROID
DOSAGE 150-450 MG/DAY
ACNE YES
WATER RETENTION LOW
HBR NO
HEPATOTOXICITY YES
AROMATIZATION YES
ACTIVE SUBSTANCE DROSTANOLONE PROPIONATE, TESTOSTERONE PROPIONATE, TRENBOLONE ACETATE
FORM 10 ML X 150 MG/ML
MANUFACTURER PARA PHARMA
DISEASE INDICATIONS: Risk of cardiovascular events
MANUFACTURER: Novartis
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Entresto is a combination medication used to treat chronic heart failure in adults, containing sacubitril and valsartan.
